Drug Approvals
🇺🇸 FDA Page 7FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 73–84 of 665 articles
Alabama Board of Medical Examiners Issues Warning on Non-FDA-Approved Peptides: What Pharma Teams Need to Know
FDA · 4 min
Dr. Sarah MitchellVertex Announces FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
FDA · IgA Nephropathy · 4 min
Dr. Sarah MitchellAurobindo Pharma OAI Classification: Implications for Drug Approvals
FDA · 5 min
Dr. Sarah MitchellLee, Tuberville Introduce Protections for Homeopathic Medicine with FDA Approval Framework
FDA · 4 min
Dr. Sarah MitchellDaraxonrasib Doubles Survival in Pancreatic Cancer: What Pharma Teams Need to Know
pancreatic cancer · 4 min
Dr. Sarah MitchellFDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis
FDA · COVID-19 · 5 min
Dr. Sarah MitchellFDA Priority Review Voucher Program: Will Makary's Initiative Survive?
FDA · 7 min
Dr. Sarah MitchellTip Sheet GLP-1s and Cancer: Key Insights for Pharma BD and Investors
oncology · 5 min
Dr. Sarah MitchellGrail’s Galleri Trial Missed Its Primary Endpoint: What BD Teams and Investors Need to Know
cancer · 5 min
Dr. Sarah MitchellTop 10 Pharmaceutical Stocks to Buy for June 2026: A B2B Analysis
EMA · 7 min
Dr. Sarah MitchellFDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies
FDA · 6 min
Dr. Sarah MitchellSTAT Supreme Court backs generic drugmaker in 'skinny labeling' case: Implications for pharma BD and investors
Supreme Court · 6 min
Dr. Sarah MitchellExplore intelligence